These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39416734)

  • 1. Challenges and Considerations in Selecting Animal Models for Evaluating a Live, Cold-Chain-Free, Dual-Use Vaccine (MyChol) for Diarrhoeal Diseases: A Comprehensive Review.
    Tew HX; Subramani P; Chan YY; Nik Mohd Noor NZ; Guruswamy P
    Malays J Med Sci; 2024 Oct; 31(5):41-55. PubMed ID: 39416734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic
    Hui Xian T; Parasuraman S; Ravichandran M; Prabhakaran G
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.
    Xian TH; Sinniah K; Yean CY; Krishnamoorthy V; Bahari MB; Ravichandran M; Prabhakaran G
    BMC Immunol; 2020 May; 21(1):29. PubMed ID: 32450807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscularly Administered Enterotoxigenic
    Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
    Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine-A Research and Development Journey: Light at the End of a Long Tunnel.
    Ravichandran M; Tew HX; Prabhakaran G; Parasuraman S; Norazmi MN
    Malays J Med Sci; 2022 Apr; 29(2):1-7. PubMed ID: 35528817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
    Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
    Svennerholm AM
    Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine.
    Murugaiah C; Nik Mohd Noor NZ; Mustafa S; Manickam R; Pattabhiraman L
    PLoS One; 2014; 9(2):e81817. PubMed ID: 24505241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
    Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
    Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity.
    Huang J; Duan Q; Zhang W
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29802193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.
    Coria LM; Martinez FL; Bruno LA; Pasquevich KA; Cassataro J
    Vaccine; 2020 Jul; 38(32):5027-5035. PubMed ID: 32536545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant infection of enterotoxigenic Escherichia coli in an outbreak of cholera caused by Vibrio cholerae O1 and O139 in Ahmedabad, India.
    Chakraborty S; Deokule JS; Garg P; Bhattacharya SK; Nandy RK; Nair GB; Yamasaki S; Takeda Y; Ramamurthy T
    J Clin Microbiol; 2001 Sep; 39(9):3241-6. PubMed ID: 11526157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
    Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
    Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.